Stay updated on Empagliflozin in Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin in Heart Failure Clinical Trial page.

Latest updates to the Empagliflozin in Heart Failure Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov page footer version was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a modification to the study information shown.SummaryDifference0.1%

- Check9 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page now shows a new system revision label 'Revision: v3.5.0' and the previous 'Revision: v3.4.3' entry has been removed.SummaryDifference0.1%

- Check52 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check74 days agoChange DetectedA new site revision, v3.4.2, was added and the previous revision v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1, a minor platform update with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Empagliflozin in Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin in Heart Failure Clinical Trial page.